Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 28,660 | 19,960 | 25,256 | 25,402 | 30,357 |
| Marketable Securities | 76,756 | 70,791 | 70,656 | 74,404 | 74,957 |
| Receivables | 4,814 | 5,565 | 4,680 | 194 | 250 |
| TOTAL | $110,230 | $96,316 | $100,592 | $104,202 | $108,790 |
| Non-Current Assets | |||||
| PPE Net | 750 | 761 | 811 | 868 | 942 |
| Investments And Advances | 85,372 | 60,612 | 71,297 | 81,084 | 85,211 |
| Other Non-Current Assets | 2,368 | 2,771 | 2,834 | 2,993 | 3,151 |
| TOTAL | $88,490 | $64,144 | $74,942 | $84,945 | $89,304 |
| Total Assets | $198,720 | $160,460 | $175,534 | $189,147 | $198,094 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14,731 | 13,158 | 9,187 | 8,797 | 6,354 |
| Accrued Expenses | 5,896 | 8,791 | 9,784 | 11,411 | 8,572 |
| TOTAL | $27,370 | $28,645 | $25,631 | $26,839 | $21,514 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 3,972 | 3,943 | 3,925 | 3,914 | 3,888 |
| Other Non-Current Liabilities | 12,416 | 12,565 | 12,311 | 12,351 | 13,308 |
| TOTAL | $27,701 | $28,733 | $29,803 | $30,569 | $32,514 |
| Total Liabilities | $55,071 | $57,378 | $55,434 | $57,408 | $54,028 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 139,664 | 120,595 | 108,345 | 108,332 | 108,281 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -987,608 | -967,784 | -947,989 | -933,375 | -917,946 |
| Other shareholders' equity | 22 | 610 | 597 | 482 | 434 |
| TOTAL | $143,649 | $103,082 | $120,100 | $131,739 | $144,066 |
| Total Liabilities And Equity | $198,720 | $160,460 | $175,534 | $189,147 | $198,094 |